Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects

NCT07054255 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Test formulation (Ranolazine extended-release tablets)
DRUG: Reference formulation (Ranolazine extended-release tablets)

Sponsor

Haisco Pharmaceutical Group Co., Ltd.